Genomics and Proteomics Find Home in BioDefense | GenomeWeb

BALTIMORE, March 11 - Genomics and proteomics may have lost some of their luster on Wall Street in recent months, but on

Aliceanna Street
here at the American Society for Microbiology Biodefense conference these subdisciplines have found a home. Along with several presentations, a good 20 percent of the posters presented applications of large-scale gene and protein analysis to understanding of pathogens and how to combat them.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.